Posts

Showing posts with the label repurposed drugs

Mebendazole for Cancer: Early Phase Data (2026)

Image
By CancerTreatmentsResearch.com . Background: In the European countries Mebendazole can be found on the supermarket shelves. Mebendazole is an anthelmintic drug that has been used since the early 1970s to treat a range of parasitical worm infections, including threadworm, tapeworms, roundworms, and other nematode and trematode infections in humans and domestic animals ( Ref .). The drug is among those on the World Health Organization’s list (WHO) ( Ref .). Mebendazole became and remained one of my preferred drugs since I learned about it at the beginning of 2014. This was mainly due to the multiple strong points that are defining Mebendazole. Those strong points are: it has high potential for serious effectiveness against cancer supported by both a large number of scientific publications ( Ref .) and clear case reports in humans, where, Mebendazole alone was effective in indu...

Fenbendazole in Oncology: Mechanism, Case Reports, and Clinical Limitations (2026)

Image
Abstract Fenbendazole (FBZ), a benzimidazole-class anthelmintic primarily used in veterinary medicine, has garnered attention for its potential anticancer properties. This review examines anecdotal reports and case studies regarding the use of fenbendazole, an anthelmintic agent traditionally used in veterinary medicine, as a potential anticancer treatment in humans. A compilation of more than 300 case reports across various cancer types, including breast, lung, colorectal, prostate, and pancreatic cancers, is analyzed to assess the validity of these claims. While these anecdotal accounts suggest potential anticancer effects of fenbendazole, the lack of controlled clinical trials necessitates caution. Healthcare professionals should be consulted before considering fenbendazole as a treatment option. Keywords: Fenbendazole; Anthelmintic; Drug repurposing; Cancer treatment; Case reports; Ivermectin; Mebendazole Introduction Managing aggressive cancers r...

Ivermectin and Mebendazole in Lymphoma and Leukemia: 42 Case Reports (August 2026 Update)

Image
Medically Reviewed by: OneDayMD Editorial Team | Last Updated: July 2026 Contents: Introduction Lymphoma Case Series (27 case reports) Leukemia Case Series (14 case reports) Discussion Conclusion Important Disclaimers:  This content is for educational purposes only and does not constitute medical advice. Ivermectin is used off-label for cancer treatment. Always consult with a knowledgeable physician whom you trust to manage your health. Individual results may vary. Do not self-medicate with ivermectin without proper bloodwork and medical monitoring, as misuse can lead to serious side effects and drug interactions. Ivermectin and mebendazole are used off-label as complementary therapies and are not intended to replace conventional, evidence-based cancer treatments such as chemotherapy, radiotherapy, immunotherapy, targeted therapy, or hormone therapy. Any off-label use should be discussed with and supervised by a qualified physician as part of an individualized treatment plan. Non...

Labels

Show more

Archive

Show more